Gold Rises Over 1%; Arcos Dorados Shares Fall After Q1 Results
U.S. stocks traded higher toward the end of trading, with the S&P 500 gaining around 1% on Wednesday.…
Why Bolt Biotherapeutics Shares Are Trading Lower By Around 34%? Here Are Other Stocks Moving In Wednesday’s Mid-Day Session
Shares of Bolt Biotherapeutics, Inc. (NASDAQ:BOLT) fell sharply during Wednesday’s session after the company reported first-quarter financial results.…
12 Health Care Stocks Moving In Wednesday’s Intraday Session
Gainers SINTX Techs (NASDAQ:SINT) stock moved upwards by 136.2% to $0.13 during Wednesday’s regular session. The company’s market…
Nasdaq Surges 150 Points; Retail Sales Flat For April
U.S. stocks traded higher midway through trading, with the Nasdaq Composite gaining around 150 points on Wednesday. The…
Expert Ratings For OptimizeRx
OptimizeRx (NASDAQ:OPRX) has been analyzed by 5 analysts in the last three months, revealing a diverse range of…
12 Health Care Stocks Moving In Tuesday’s After-Market Session
Gainers Arcutis Biotherapeutics (NASDAQ:ARQT) stock moved upwards by 16.4% to $9.46 during Tuesday’s after-market session. The company’s market…
OptimizeRx Corporation Says 1Q24 Revenue Expected To Grow Over 40% YoY And Come In Between $18.5M-$19.2M Vs. $17.03M Estimate; Company Says DAAP Adoption And Cross Selling Activities Are Tracking Ahead Of Internal Expectations
For the first quarter, the Company expects revenue to increase over 40% year-over-year and come in between $18.5 million and $19.2 million with a GAAP net loss and Adjusted EBITDA loss between $(8.2) - $(7.0) million and
Where OptimizeRx Stands With Analysts
Throughout the last three months, 4 analysts have evaluated OptimizeRx (NASDAQ:OPRX), offering a diverse set of opinions from…
Earnings Scheduled For March 28, 2024
Companies Reporting Before The Bell
• Universal Stainless (NASDAQ:USAP) is expected to report quarterly earnings at $0.32 per share on revenue of $78.65 million.
OptimizeRx Earnings Preview
OptimizeRx (NASDAQ:OPRX) is set to give its latest quarterly earnings report on Thursday, 2024-03-28. Here’s what investors need…